Dr Beicheng Sun
Associate Editor: Beicheng Sun
Dr. Sun is a professor and surgeon at Nanjing University where he serves as the Vice president of The Affiliated Drum Tower Hospital of Nanjing University Medical School. In 2001, he obtained his MD-PhD degree in Nanjing Medical University, China. As a postdoctoral fellow at The University of Texas Health Science Center at San Antonio, he devoted in the telomerase-related cancer research. As a surgeon, he is skilled in liver transplantation and Hepatectomy. Dr. Sun's researches mainly focused on inflammatory-related carcinogenesis. His team discovered the potential therapeutic values and mechanistic roles of cytokines in hepatocarcinogenesis including IL-22, IL-17A, and IL-1α, etc. His team also explored the cell signaling involving in the malfunction of tumor infiltrated Leucocytes (TILs), they clarified the roles of PTPRO/STAT3, PTPRO/NF-κB, and Lnc-EGFR/EGFR/AP-1 signaling in the immunosuppressive-transform of T cell and macrophage. His current research interests are inflammatory related metabolic disorders in TILs, aiming to clarify the metabolism-related links in T cell exhausting and NK cell malfunction. Meanwhile, clinical trials of immunotherapy are in procession using CAR-T and CRISPR-Cas9. Dr. Sun is the Yangtze River Scholar Professor of Chinese Ministry of Education, and he also obtained a National Science Fund for Distinguished Young Scholars. He is an Associate Editor of Plos One and Associate Editor of World Journal of Gastroenterology, the member of the Youth Committee of Chinese Organ Transplantation Society of Chinese Medical Association and the Executive Committee of Chinese Society of Liver Cancer, Chinese Anti-Cancer Association.